Concentric Capital Strategies’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-91,881
Closed -$13M 317
2025
Q4
$13M Buy
+91,881
New +$10.4M 0.62% 41
2024
Q4
Sell
-18,386
Closed -$1.74M 254
2024
Q3
$1.74M Buy
18,386
+8,136
+79% +$722K 0.07% 206
2024
Q2
$979K Sell
10,250
-2,581
-20% -$307K 0.05% 247
2024
Q1
$1.69M Buy
12,831
+10,978
+592% +$1.35M 0.1% 214
2023
Q4
$268K Sell
1,853
-3,681
-67% -$505K 0.03% 201
2023
Q3
$941K Buy
+5,534
New +$1.1M 0.1% 141

Other funds holding ALB

Concentric Capital Strategies's ALB Position: Q1 2026 in Review

Concentric Capital Strategies sold out of Albemarle (ALB) in Q1 2026, closing a stake of 91,881 shares — an estimated $13M sold.

Concentric Capital Strategies first reported a position in ALB in Q3 2023 and held it in 6 quarters. The position peaked at $13M in Q4 2025. 982 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

  • Concentric Capital Strategies reported no remaining Albemarle position as of Q1 2026 after selling out during the quarter.
  • Concentric Capital Strategies sold 91,881 Albemarle shares in Q1 2026, an estimated $13M.
  • Concentric Capital Strategies first reported a position in Albemarle in Q3 2023 and held it in 6 quarters.
  • Concentric Capital Strategies's Albemarle position peaked at $13M in Q4 2025.
  • 982 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on Concentric Capital Strategies's 13F filing for Q1 2026, filed 15 May 2026.